|
Protecting domestic generic drug manufacturing is vital to national pharmacare plan
Friday, April 15th, 2022
The federal commitment to national pharmacare presents an opportunity to improve prescription drug coverage for Canadians, reduce costs to taxpayers and patients through increased use of generic medicines, and to strengthen our domestic pharmaceutical manufacturing sector and international supply chain.
Tags: budget, economy, globalization, Health, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Recent Comments